Intracellular protein binders for imaging, control, and future therapeutics
Intracellular protein dysregulation underlies many cancers, neurodegenerative disorders, and infectious diseases, yet a substantial fraction of the human proteome remains inaccessible to conventional small-molecule drugs or extracellular antibodies. Genetically encoded intracellular binders, including nanobodies, DARPi...